SCHEMBL17599464

SCHEMBL17599464

CCCCCCCCn1nc(C)c(S(=O)(=O)Nc2ccc(N3CC[C@@H](C(=O)O)C3)c3ncccc23)c1C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 7/20 0.66
▸ NFE2L2 Q16236 1/20 0.50
▸ CTSB P07858 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.35
▸ MMP2 P08253 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ GFER P55789 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ SLC40A1 Q9NP59 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ PDE5A O76074 1/20 0.33
▸ NOTUM Q6P988 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17612856 0.93 KEAP1 (0.56) KEAP1NFE2L2CTSBKDM4EALDH1A1
SCHEMBL17612896 0.90 KEAP1 (0.62) KEAP1NFE2L2SMN1; SMN2NOTUM
SCHEMBL17599508 0.90 KEAP1 (0.62) KEAP1NFE2L2SMN1; SMN2NOTUM
SCHEMBL17599497 0.83 KEAP1 (0.75) KEAP1NFE2L2CTSBTDP1MMP2
SCHEMBL17599448 0.80 KEAP1 (0.73) KEAP1NFE2L2CTSBTDP1MMP2
SCHEMBL17612884 0.80 KEAP1 (1.00) KEAP1NFE2L2CTSBTDP1MMP2
SCHEMBL17599451 0.80 KEAP1 (1.00) KEAP1NFE2L2CTSBTDP1MMP2
SCHEMBL17599418 0.80 KEAP1 (1.00) KEAP1NFE2L2CTSBTDP1MMP2
SCHEMBL17599512 0.76 KEAP1 (0.71) KEAP1NFE2L2GAASMN1; SMN2NOTUM
SCHEMBL17599511 0.76 KEAP1 (0.71) KEAP1NFE2L2GAASMN1; SMN2NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997966-A1 Naphthyl Sulfonamide Pyrrolidine Derivatives as KEAP-1 Modulators for the Treatment of Diabetes, Obesity, Dyslipidemia and Related Disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback